Clinical Approach to Petechiae and Purpura
Pediatric Comprehensive Framework1. Symptom Overview
Understanding the clinical significance and classification of petechiae and purpura in children
Petechiae and purpura are among the most anxiety-provoking findings in pediatric practice, as they may herald life-threatening conditions such as meningococcemia or leukemia. However, these lesions are common in children, with benign etiologies accounting for the majority of cases. Approximately 2-3% of children presenting to emergency departments with petechiae or purpura have serious underlying bacterial infections. Immune thrombocytopenic purpura (ITP), the most common cause of isolated thrombocytopenia in children, has an annual incidence of 4-5 per 100,000 children, with peak incidence between ages 2-5 years. Henoch-Schönlein purpura (IgA vasculitis) affects approximately 10-20 per 100,000 children annually, most commonly between ages 3-10 years.
Definition
Petechiae are pinpoint, non-blanching, red-purple lesions less than 2 mm in diameter caused by intradermal or submucosal hemorrhage. Purpura refers to larger non-blanching lesions measuring 2 mm to 1 cm. Lesions greater than 1 cm are termed ecchymoses. The key distinguishing feature is that these lesions do not blanch with pressure because blood has extravasated from the vasculature into surrounding tissues.
Key Epidemiology
- Fever with petechiae: 2-3% have serious bacterial infection; approximately 7-10% of febrile children with petechiae have meningococcal disease in endemic areas
- Immune thrombocytopenic purpura: 4-5 per 100,000 children per year; peak age 2-5 years; equal gender distribution
- Henoch-Schönlein purpura: 10-20 per 100,000 children per year; peak age 3-10 years; male predominance (2:1)
- Mechanical petechiae: Most common benign cause; often seen after vigorous coughing, vomiting, or crying
Classification by Size
| Lesion Type | Size | Typical Appearance | Clinical Significance |
|---|---|---|---|
| Petechiae | Less than 2 mm | Pinpoint, flat, red-purple spots | May be benign (mechanical) or indicate thrombocytopenia, sepsis, or vasculitis |
| Purpura | 2 mm to 1 cm | Larger flat or raised lesions; may be palpable in vasculitis | More likely pathological; consider vasculitis, coagulopathy, or sepsis |
| Ecchymoses | Greater than 1 cm | Large bruise-like areas; evolve in color over time | Consider trauma, coagulation disorders, or non-accidental injury |
Classification by Distribution
| Distribution Pattern | Description | Typical Causes | Clinical Implication |
|---|---|---|---|
| Superior Vena Cava Distribution | Face, head, neck, upper chest; above nipple line | Mechanical causes: coughing, vomiting, crying, strangulation | Often benign if isolated and well child; consider pertussis or non-accidental injury |
| Dependent Distribution | Lower extremities, buttocks; gravity-dependent areas | Henoch-Schönlein purpura, vasculitis | Classic for IgA vasculitis; palpable suggests small vessel vasculitis |
| Generalized Distribution | Widespread across body; trunk and extremities | Thrombocytopenia, sepsis, leukemia, disseminated intravascular coagulation | Higher concern for systemic disease; requires urgent evaluation |
| Localized or Unilateral | Confined to one area or limb | Trauma, tourniquet effect, local infection | Consider non-accidental injury if pattern unusual for stated mechanism |
Classification by Palpability
Non-Palpable (Macular) Purpura
Mechanism: Bleeding from damaged vessels or platelet/coagulation defects
Causes include:
- Thrombocytopenia (immune thrombocytopenic purpura, leukemia, aplastic anemia)
- Platelet dysfunction
- Coagulation factor deficiencies
- Mechanical causes (coughing, vomiting)
- Sepsis with disseminated intravascular coagulation
Palpable Purpura
Mechanism: Inflammatory damage to vessel walls (vasculitis)
Causes include:
- Henoch-Schönlein purpura (IgA vasculitis)
- Other small vessel vasculitides
- Septic emboli (acute bacterial endocarditis)
- Meningococcemia (early lesions may be palpable)
- Drug-induced vasculitis
Classification by Clinical Context
| Clinical Scenario | Key Features | Primary Considerations | Urgency |
|---|---|---|---|
| Well Child with Petechiae | Afebrile, active, localized lesions (especially face/chest) | Mechanical causes, immune thrombocytopenic purpura | Routine to urgent |
| Febrile Child with Petechiae | Fever plus non-blanching rash; may appear ill | Meningococcemia, other sepsis, viral infection with thrombocytopenia | Emergent until proven otherwise |
| Purpura with Joint or Abdominal Pain | Palpable purpura on lower limbs/buttocks, arthralgia, colicky abdominal pain | Henoch-Schönlein purpura (IgA vasculitis) | Urgent |
| Purpura with Pallor and Fatigue | Generalized petechiae/purpura, pallor, lymphadenopathy, hepatosplenomegaly | Leukemia, aplastic anemia, bone marrow failure | Emergent |
Age-Specific Considerations
| Age Group | Common Causes | Special Considerations |
|---|---|---|
| Neonate (0-28 days) | Congenital infections (TORCH), neonatal alloimmune thrombocytopenia, sepsis, birth trauma | Maternal antibodies may cause thrombocytopenia; congenital thrombocytopenia syndromes; “blueberry muffin” rash suggests congenital infection or neuroblastoma |
| Infant (1-12 months) | Viral infections, sepsis, non-accidental injury, rare inherited disorders | High index of suspicion for non-accidental injury; facial petechiae from crying common but must exclude strangulation |
| Toddler (1-3 years) | Immune thrombocytopenic purpura, Henoch-Schönlein purpura, viral infections, meningococcemia | Peak age for immune thrombocytopenic purpura; often follows viral illness; bruising on shins common from normal play |
| School Age (4-12 years) | Henoch-Schönlein purpura, immune thrombocytopenic purpura, leukemia, mechanical causes | Peak age for Henoch-Schönlein purpura; leukemia can present at any age; consider von Willebrand disease |
| Adolescent (13-18 years) | Immune thrombocytopenic purpura (may become chronic), systemic lupus erythematosus, infectious mononucleosis | Drug-induced causes more common; systemic lupus erythematosus predominantly affects adolescent females; consider menorrhagia as presenting complaint |
Key Clinical Principle: The critical first question when assessing a child with petechiae or purpura is: “Is this child well or unwell?” A febrile, ill-appearing child with petechiae or purpura must be treated as sepsis (particularly meningococcemia) until proven otherwise. In contrast, a well-appearing, afebrile child with localized petechiae above the nipple line following coughing or vomiting likely has benign mechanical petechiae, though serious causes must still be excluded.
2. Pathophysiology and Mechanisms
Understanding why and how petechiae and purpura develop in children
Petechiae and purpura result from extravasation of red blood cells from the intravascular compartment into the skin or mucous membranes. Understanding the hemostatic system and the mechanisms that lead to its failure is essential for determining the underlying cause. Normal hemostasis requires intact blood vessels, adequate platelet number and function, and a functional coagulation cascade. Disruption at any of these levels can result in petechiae, purpura, or more extensive bleeding.
Normal Hemostasis: The Three Components
| Component | Function | Key Elements | Defect Results In |
|---|---|---|---|
| Vascular Integrity | Contains blood within vessels; vasoconstriction limits bleeding | Endothelium, collagen, basement membrane, smooth muscle | Palpable purpura (vasculitis), easy bruising (connective tissue disorders) |
| Primary Hemostasis | Forms initial platelet plug at site of injury | Platelets, von Willebrand factor, platelet glycoprotein receptors | Petechiae, mucosal bleeding, superficial bleeding |
| Secondary Hemostasis | Stabilizes platelet plug with fibrin clot | Coagulation factors (I-XIII), thrombin, fibrinogen | Deep tissue bleeding, hemarthroses, delayed bleeding after trauma |
Mechanisms of Petechiae and Purpura Formation
Thrombocytopenia
Definition: Platelet count less than 150 × 10⁹/L; clinical bleeding typically occurs below 20-30 × 10⁹/L
Mechanisms:
- Decreased production (marrow failure, infiltration, infection)
- Increased destruction (immune-mediated, consumptive)
- Sequestration (hypersplenism)
- Dilutional (massive transfusion)
Clinical features: Mucocutaneous bleeding, petechiae, epistaxis, gum bleeding
Platelet Dysfunction
Definition: Impaired platelet function despite normal platelet count
Mechanisms:
- Inherited disorders (Glanzmann thrombasthenia, Bernard-Soulier syndrome)
- Acquired (uremia, medications, myeloproliferative disorders)
- von Willebrand disease (impaired platelet adhesion)
Clinical features: Similar to thrombocytopenia; prolonged bleeding time with normal platelet count
Vascular Damage
Definition: Direct injury or inflammation of vessel walls
Mechanisms:
- Vasculitis (immune complex deposition, direct infection)
- Mechanical trauma (increased venous pressure)
- Connective tissue defects (Ehlers-Danlos syndrome)
- Vitamin C deficiency (scurvy)
Clinical features: Palpable purpura in vasculitis; perifollicular hemorrhage in scurvy
Pathophysiology by Condition
| Condition | Mechanism | Why It Causes Petechiae/Purpura | Distinguishing Features |
|---|---|---|---|
| Immune Thrombocytopenic Purpura | Autoantibodies (usually IgG) bind to platelet surface glycoproteins (GPIIb/IIIa, GPIb/IX); antibody-coated platelets are destroyed by splenic macrophages | Profound thrombocytopenia (often less than 20 × 10⁹/L) with inadequate platelets to maintain vascular integrity | Otherwise well child; often follows viral illness; isolated thrombocytopenia; normal or increased megakaryocytes in marrow |
| Henoch-Schönlein Purpura (IgA Vasculitis) | IgA-containing immune complexes deposit in small vessel walls, triggering complement activation and neutrophil infiltration; results in leukocytoclastic vasculitis | Inflammatory destruction of vessel walls leads to red blood cell extravasation; inflammation causes palpable purpura | Palpable purpura on dependent areas; normal platelet count; often follows upper respiratory tract infection; may have arthritis, abdominal pain, nephritis |
| Meningococcemia | Neisseria meningitidis endotoxin activates coagulation cascade and causes direct endothelial damage; leads to disseminated intravascular coagulation and vascular thrombosis | Combination of consumptive thrombocytopenia, consumption of clotting factors, and direct vascular injury | Ill-appearing febrile child; rapidly progressive rash; lesions may be petechial, purpuric, or necrotic; hemodynamic instability |
| Leukemia | Malignant cells infiltrate bone marrow, suppressing normal hematopoiesis; results in decreased platelet production (and often anemia and neutropenia) | Thrombocytopenia from marrow failure; may also have coagulopathy, especially in acute promyelocytic leukemia | Fatigue, pallor, hepatosplenomegaly, lymphadenopathy; pancytopenia common; blasts on peripheral smear |
| Mechanical Petechiae | Sudden increase in venous pressure (coughing, vomiting, crying, straining) exceeds capillary wall strength, causing rupture without underlying hemostatic defect | Transient pressure-induced capillary rupture in superior vena cava distribution (above nipple line) | Well child; localized to face, neck, chest; history of precipitating event; no mucosal involvement; resolves within days |
| Disseminated Intravascular Coagulation | Systemic activation of coagulation leads to widespread fibrin deposition, consumption of platelets and clotting factors, and secondary fibrinolysis | Combined thrombocytopenia and clotting factor deficiency; microvascular thrombosis causes tissue ischemia | Seriously ill child; underlying trigger (sepsis, trauma, malignancy); bleeding from multiple sites; prolonged PT and aPTT; elevated D-dimer; low fibrinogen |
| von Willebrand Disease | Deficiency or dysfunction of von Willebrand factor impairs platelet adhesion to damaged endothelium and may reduce factor VIII levels | Inadequate primary hemostasis despite normal platelet count; bleeding disproportionate to trauma | Mucocutaneous bleeding, menorrhagia, prolonged bleeding after procedures; family history; normal platelet count; prolonged bleeding time or PFA-100 |
Why Location Matters: Vascular Anatomy
Superior Vena Cava Distribution
The venous drainage from the head, neck, and upper chest flows into the superior vena cava, which lacks valves. During episodes of increased intrathoracic or intra-abdominal pressure (coughing, vomiting, crying, straining), venous pressure rises dramatically in this territory.
Result: Capillaries in the face, conjunctivae, neck, and upper chest rupture, causing petechiae confined to this distribution.
Clinical implication: Petechiae isolated to this distribution in a well child, with a clear history of a precipitating event, suggests benign mechanical cause.
Dependent (Lower Extremity) Distribution
Hydrostatic pressure is highest in dependent areas due to gravity. In conditions affecting small vessels (vasculitis), immune complexes preferentially deposit where flow is slowest and pressure is highest.
Result: Palpable purpura concentrated on the lower extremities and buttocks, especially in ambulatory children.
Clinical implication: This distribution is classic for Henoch-Schönlein purpura (IgA vasculitis) and should prompt evaluation for systemic involvement.
Pediatric-Specific Pathophysiological Considerations
| Age-Related Factor | Pathophysiological Significance | Clinical Relevance |
|---|---|---|
| Neonatal Hemostasis | Vitamin K-dependent factors (II, VII, IX, X) are physiologically low at birth; platelet function may be mildly impaired | Without vitamin K prophylaxis, neonates are at risk for hemorrhagic disease of the newborn; always verify vitamin K was given |
| Maternal Antibody Transfer | Maternal IgG antiplatelet antibodies cross the placenta and can cause neonatal alloimmune thrombocytopenia (NAIT) or neonatal autoimmune thrombocytopenia | Thrombocytopenic neonate may have mother with immune thrombocytopenic purpura or HPA alloimmunization; resolves as maternal antibodies clear |
| Immature Immune Regulation | Post-viral immune dysregulation in young children may trigger autoantibody formation against platelets | Immune thrombocytopenic purpura often follows viral illness by 1-4 weeks; usually self-limited in children (80% resolve within 6 months) |
| Developing Vasculature | Small vessel walls may be more susceptible to immune complex deposition in certain age groups | Henoch-Schönlein purpura peaks at ages 3-10 years; rare in infants and adults |
| Bone Marrow Composition | In children, bone marrow is more cellular and may be more susceptible to viral suppression or infiltration | Transient marrow suppression from viral infections may cause thrombocytopenia; malignant infiltration may present earlier |
Often Overlooked Mechanism: The Role of Endothelial Dysfunction
Beyond platelets and coagulation factors, the vascular endothelium plays a critical role in hemostasis. Endothelial cells normally prevent coagulation by producing anticoagulant substances (nitric oxide, prostacyclin) and binding antithrombin. In sepsis and systemic inflammation, endothelial activation and damage disrupt this balance, contributing to both thrombosis and hemorrhage. This explains why children with meningococcemia can have both purpura fulminans (thrombosis) and bleeding simultaneously—the endothelium is diffusely dysfunctional.
Complications of Petechiae and Purpura
| Underlying Mechanism | Potential Complications | Clinical Monitoring |
|---|---|---|
| Severe Thrombocytopenia | Intracranial hemorrhage (most feared); gastrointestinal bleeding; hematuria | Neurological status; signs of internal bleeding; platelet count monitoring |
| Henoch-Schönlein Purpura | Nephritis (occurs in up to 50%); intussusception; scrotal involvement; rarely nephrotic syndrome or chronic renal disease | Urinalysis weekly for several months; blood pressure; abdominal examination; testicular examination in boys |
| Meningococcemia | Purpura fulminans; multi-organ failure; limb loss; adrenal hemorrhage (Waterhouse-Friderichsen syndrome); death | Continuous hemodynamic monitoring; coagulation studies; limb perfusion assessment |
| Leukemia | Tumor lysis syndrome with treatment; infection due to neutropenia; anemia requiring transfusion | Complete blood count monitoring; infectious precautions; electrolyte monitoring with treatment |
Key Pathophysiological Principle: Petechiae and purpura indicate failure of the hemostatic system at one or more levels. The distribution, palpability, and associated clinical features help identify which component is affected:
- Generalized, non-palpable petechiae: Think platelet problem (thrombocytopenia or dysfunction)
- Palpable purpura on dependent areas: Think vascular problem (vasculitis)
- Purpura with deep tissue bleeding: Think coagulation problem (factor deficiency)
- Localized petechiae in superior vena cava distribution: Think mechanical cause if well child
3. History Taking
A comprehensive approach to eliciting the history of petechiae and purpura in children
Red Flags — Require Urgent Evaluation
- Fever with petechiae/purpura — Meningococcemia, sepsis until proven otherwise
- Ill-appearing child — Sepsis, disseminated intravascular coagulation, leukemia
- Rapidly spreading rash — Meningococcemia, purpura fulminans
- Altered mental status — Intracranial hemorrhage, meningitis, severe sepsis
- Signs of shock — Tachycardia, poor perfusion, hypotension (late sign in children)
- Mucosal bleeding — Severe thrombocytopenia, risk of intracranial hemorrhage
- Headache or vomiting — May indicate intracranial hemorrhage
- Pallor and fatigue — Bone marrow failure, leukemia
- Unexplained bruising in non-mobile infant — Non-accidental injury, serious hematological disorder
- Lymphadenopathy or hepatosplenomegaly — Leukemia, lymphoma, infection
Systematic History: The “PURPLE” Approach
Use the mnemonic “PURPLE” to ensure comprehensive history taking for petechiae and purpura:
- P — Pattern and Progression: When did it start? How quickly did it spread? Is it getting worse or better? What did the first lesions look like?
- U — Underlying Triggers: Recent illness (especially viral)? Coughing, vomiting, or crying episodes? Trauma? New medications? Immunizations?
- R — Related Symptoms: Fever? Joint pain? Abdominal pain? Headache? Bleeding from other sites (gums, nose, urine, stool)?
- P — Past Medical and Family History: Previous bleeding problems? Family history of bleeding disorders, autoimmune conditions, or malignancy?
- L — Location and Appearance: Where on the body? Above or below the nipple line? Flat or raised (palpable)? Size of lesions?
- E — Eating, Energy, and General Health: How is the child’s appetite? Activity level? Weight loss? Night sweats? Overall wellbeing?
Essential Questions by Suspected Cause
| Suspected Cause | Key Features | Ask This Question |
|---|---|---|
| Mechanical Petechiae | Localized to face/neck/chest; well child; clear precipitant | “Was your child coughing hard, vomiting, crying intensely, or straining before you noticed the spots?” |
| Immune Thrombocytopenic Purpura | Well child; sudden onset; often post-viral; widespread petechiae | “Did your child have a cold, flu, or viral illness in the past 1-4 weeks? Has your child been otherwise well and active?” |
| Henoch-Schönlein Purpura | Palpable purpura on legs/buttocks; joint and abdominal pain | “Has your child complained of pain in their joints, especially ankles or knees? Any tummy pain or blood in the stool or urine?” |
| Meningococcemia | Febrile, ill child; rapidly progressive rash; may have neck stiffness | “How quickly has the rash spread? Does your child seem very unwell? Any neck stiffness, sensitivity to light, or extreme irritability?” |
| Leukemia | Fatigue, pallor, recurrent infections, bone pain, lymphadenopathy | “Has your child been unusually tired? Any bone or joint pain? Frequent infections? Have you noticed any lumps in the neck, armpits, or groin?” |
| Non-Accidental Injury | Pattern inconsistent with history; unusual locations; delayed presentation | “Can you tell me exactly what happened and when? Who was with the child when this occurred?” (Ask caregivers separately if possible) |
| Inherited Bleeding Disorder | Family history; recurrent bleeding; excessive bleeding with procedures | “Has your child ever had prolonged bleeding after cuts, dental work, or surgery? Does anyone in the family have a bleeding problem?” |
| Drug-Induced Thrombocytopenia | Recent new medication; onset days to weeks after starting drug | “Has your child started any new medications in the past few weeks, including over-the-counter medicines or supplements?” |
Characterizing the Rash
| Question | Why It Matters | Interpretation |
|---|---|---|
| “When did you first notice the spots?” | Acute onset suggests different causes than chronic | Sudden onset in well child: mechanical or immune thrombocytopenic purpura. Rapid progression with fever: sepsis |
| “Are the spots spreading? How quickly?” | Rate of progression indicates urgency | Rapid spread (minutes to hours) with fever: meningococcemia until proven otherwise. Gradual spread: less urgent |
| “Do the spots disappear when you press on them?” | Blanching indicates intact vessels; non-blanching indicates hemorrhage | Non-blanching confirms petechiae/purpura. Teach parents the “glass test” (press clear glass on skin) |
| “Can you feel the spots, or are they flat?” | Palpability suggests vasculitis | Palpable: think vasculitis (Henoch-Schönlein purpura). Non-palpable: think platelet or coagulation problem |
| “Where on the body are the spots?” | Distribution provides diagnostic clues | Face/neck/chest: mechanical. Lower extremities/buttocks: Henoch-Schönlein purpura. Generalized: thrombocytopenia |
Pediatric-Specific History Components
Birth and Neonatal History (Essential in Infants)
| Question | Relevance |
|---|---|
| Was vitamin K given at birth? | Without vitamin K, neonates are at risk for hemorrhagic disease of the newborn (vitamin K deficiency bleeding) |
| Any problems at birth? NICU admission? | Prematurity, sepsis, and NICU interventions increase risk of neonatal thrombocytopenia |
| Does mother have any blood disorders or autoimmune conditions? | Maternal immune thrombocytopenic purpura or platelet alloimmunization can cause neonatal thrombocytopenia |
| Any jaundice, rash, or problems in the newborn period? | Congenital infections (TORCH) can cause thrombocytopenia; “blueberry muffin” rash suggests extramedullary hematopoiesis |
Developmental History
- Meeting milestones appropriately? — Developmental delay may suggest syndromic cause of thrombocytopenia (e.g., thrombocytopenia-absent radius syndrome, Wiskott-Aldrich syndrome)
- Any regression of skills? — Unusual with bleeding disorders; consider other diagnoses if present
Immunization History
- Up to date with vaccinations? — Important for assessing infectious risk
- Recent vaccines, especially MMR? — MMR vaccine can rarely cause immune thrombocytopenic purpura (1:25,000-40,000 doses); onset typically 1-6 weeks post-vaccination
- Meningococcal vaccination status? — Determines risk of meningococcal disease
Bleeding History
| Question | Interpretation |
|---|---|
| “Any previous nosebleeds? How long do they last?” | Recurrent, prolonged epistaxis (>10-15 minutes) suggests bleeding disorder |
| “Any bleeding from gums with brushing teeth?” | Mucosal bleeding suggests platelet problem or severe coagulopathy |
| “Has your child had any dental extractions or surgery? Any excessive bleeding?” | Prolonged bleeding after procedures suggests underlying hemostatic defect |
| “For girls: heavy or prolonged menstrual periods?” | Menorrhagia is often the presenting symptom of von Willebrand disease in adolescent females |
| “Any blood in the urine or stool?” | Hematuria: consider Henoch-Schönlein purpura nephritis, severe thrombocytopenia. Bloody stool: Henoch-Schönlein purpura, intussusception |
Medication History
Medications That Can Cause Thrombocytopenia
- Antibiotics: Penicillins, cephalosporins, sulfonamides, trimethoprim-sulfamethoxazole, vancomycin
- Anticonvulsants: Valproic acid (dose-dependent), carbamazepine, phenytoin
- Heparin: Heparin-induced thrombocytopenia (rare in children)
- Chemotherapy agents: Most cause bone marrow suppression
- Immunosuppressants: Azathioprine, mycophenolate
- Nonsteroidal anti-inflammatory drugs: Rare cause of thrombocytopenia
Medications That Affect Platelet Function
- Aspirin: Irreversibly inhibits cyclooxygenase; effect lasts platelet lifespan (7-10 days)
- Nonsteroidal anti-inflammatory drugs: Reversible platelet inhibition (ibuprofen, naproxen)
- Antihistamines: May impair platelet function
- Selective serotonin reuptake inhibitors: Can affect serotonin-mediated platelet aggregation
- Herbal supplements: Fish oil, ginkgo, garlic, ginger in large doses
Family History
| Ask About | Relevance |
|---|---|
| Bleeding disorders | von Willebrand disease (autosomal dominant), hemophilia (X-linked), inherited thrombocytopenias |
| Autoimmune conditions | Systemic lupus erythematosus, immune thrombocytopenic purpura, and other autoimmune disorders may cluster in families |
| Childhood cancers | Some genetic syndromes predispose to malignancy |
| Easy bruising in family members | May indicate mild inherited bleeding disorder not formally diagnosed |
| Consanguinity | Increases risk of autosomal recessive conditions including some inherited thrombocytopenias |
Social History and Safeguarding Considerations
Non-Accidental Injury: When to Consider
- Bruising in a non-mobile infant — “Those who don’t cruise rarely bruise”
- Pattern of bruises inconsistent with stated mechanism
- Bruising in unusual locations — Ears, neck, buttocks, trunk (TEN-4 rule: Torso, Ears, Neck in any child; any bruising in child under 4 months)
- Delay in seeking medical attention
- Inconsistent history between caregivers or changing history
- Previous concerning presentations or known safeguarding issues
Remember: Bleeding disorders can coexist with non-accidental injury. A normal coagulation screen does not exclude abuse, and suspected abuse does not exclude a bleeding disorder.
Additional Social History
- Recent travel: Endemic areas for certain infections (dengue, rickettsial diseases, malaria)
- Daycare or school attendance: Viral exposure, meningococcal outbreaks
- Sick contacts: Household members with viral illnesses, meningococcal disease contacts
- Pet exposure: Tick exposure (rickettsial diseases, ehrlichiosis)
4. Physical Examination
A systematic head-to-toe approach for petechiae and purpura in children
Systematic Framework: Use the “Head to Extremities” approach for complete examination of children presenting with petechiae and purpura. The first priority is to assess how unwell the child is — a febrile, ill-appearing child with petechiae is a medical emergency until serious bacterial infection is excluded.
Initial Assessment: Is This Child Sick or Not Sick?
| Assessment Domain | Well Child | Unwell Child (Concerning) |
|---|---|---|
| Appearance | Alert, interactive, smiling, appropriate affect | Lethargic, irritable, inconsolable, weak cry, “toxic” appearance |
| Color | Normal skin color; pink mucous membranes | Pale, mottled, cyanotic, or gray |
| Activity | Active, playful, moving spontaneously | Decreased activity, not interested in surroundings, floppy |
| Feeding/Hydration | Feeding well, moist mucous membranes | Poor feeding, dry mucous membranes, reduced urine output |
Vital Signs
| Age | Heart Rate (beats/min) | Respiratory Rate (/min) | Systolic Blood Pressure (mmHg) | Temperature (°C) |
|---|---|---|---|---|
| Neonate (0-28 days) | 100-160 | 30-60 | 60-90 | 36.5-37.5 |
| Infant (1-12 months) | 100-150 | 25-40 | 80-100 | 36.5-37.5 |
| Toddler (1-3 years) | 90-140 | 20-30 | 90-105 | 36.5-37.5 |
| Preschool (3-5 years) | 80-120 | 20-25 | 95-110 | 36.5-37.5 |
| School age (6-12 years) | 70-110 | 18-25 | 100-120 | 36.5-37.5 |
| Adolescent (13-18 years) | 60-100 | 12-20 | 110-130 | 36.5-37.5 |
Vital Sign Red Flags
- Fever (≥38°C) with petechiae/purpura: Treat as potential meningococcemia until proven otherwise
- Tachycardia out of proportion to fever: May indicate compensated shock or significant anemia
- Hypotension: Late sign of shock in children — do not wait for this to initiate treatment
- Prolonged capillary refill (>2-3 seconds): Indicates poor peripheral perfusion
General Inspection
- Overall appearance: Well versus unwell; level of alertness and interaction
- Color: Pallor (anemia), jaundice (hemolysis), cyanosis or mottling (shock)
- Dysmorphic features: May suggest syndromic cause of thrombocytopenia
- Nutritional status: Wasting may suggest chronic illness or malignancy
- Signs of active bleeding: Epistaxis, gum bleeding, oozing from puncture sites
Skin Examination: Detailed Assessment of the Rash
Key Characteristics to Document
| Characteristic | How to Assess | Clinical Significance |
|---|---|---|
| Non-blanching nature | Press with finger or glass slide; petechiae/purpura do not disappear | Confirms extravasated blood rather than erythema or vascular dilation |
| Size | Measure with ruler: petechiae <2mm, purpura 2mm-1cm, ecchymoses >1cm | Larger lesions may indicate more severe bleeding tendency or vasculitic process |
| Palpability | Gently run fingers over lesions; palpable purpura is raised | Palpable: vasculitis (Henoch-Schönlein purpura). Non-palpable: platelet or coagulation problem |
| Distribution | Map lesions on body; note if above or below nipple line; unilateral or bilateral | Face/upper chest: mechanical. Lower limbs/buttocks: Henoch-Schönlein purpura. Generalized: systemic cause |
| Color and age of lesions | Fresh lesions are red-purple; older lesions become brown, yellow, green | Multiple lesions of different ages may suggest ongoing process or repeated episodes |
| Pattern | Look for linear marks, hand prints, or patterns suggesting objects | Patterned bruising raises concern for non-accidental injury |
Distribution Patterns and Their Significance
Face, Head, and Neck
Mechanical petechiae: Periorbital, face, neck after coughing/vomiting/crying
Conjunctival hemorrhage: May accompany facial petechiae
Consider: Pertussis if severe paroxysmal cough; strangulation if linear neck marks
Trunk
Generalized petechiae: Suggests thrombocytopenia if widespread
Unusual location for accidental bruising: Consider non-accidental injury if on back, buttocks, or torso
Dermatomal distribution: May suggest herpes zoster with thrombocytopenia
Upper Extremities
Shins/extensor surfaces: Normal bruising area in mobile children
Blood pressure cuff site: May see petechiae (tourniquet effect) in thrombocytopenia
IV access sites: Prolonged bleeding or hematoma formation
Lower Extremities and Buttocks
Classic Henoch-Schönlein purpura distribution: Palpable purpura on buttocks, posterior thighs, lower legs
Gravitationally dependent: In ambulatory children, lesions concentrate on legs
Shins: Common site for accidental bruising in mobile children
Head, Eyes, Ears, Nose, and Throat Examination
Eyes
- Conjunctival hemorrhages: May accompany facial petechiae; also seen in severe thrombocytopenia
- Retinal hemorrhages: Require fundoscopy; concerning for intracranial pathology or non-accidental injury
- Jaundice: Scleral icterus suggests hemolysis
- Periorbital edema: May indicate nephrotic syndrome secondary to Henoch-Schönlein purpura nephritis
Mouth and Throat
- Mucosal petechiae: Palate, buccal mucosa; indicates severe thrombocytopenia with increased bleeding risk
- Gum hypertrophy: May suggest leukemia (especially acute monocytic leukemia)
- Blood blisters: Hemorrhagic bullae indicate severe thrombocytopenia
- Tonsillar petechiae: May be seen with infectious mononucleosis
Neck Examination
- Lymphadenopathy: Enlarged nodes may suggest infection, leukemia, or lymphoma; assess size, consistency, tenderness, mobility
- Meningism: Neck stiffness, positive Brudzinski or Kernig signs; concerning for meningitis with petechiae
- Petechiae in unusual patterns: Linear marks around neck raise concern for strangulation
Respiratory Examination
- Work of breathing: Tachypnea may indicate acidosis in sepsis or pulmonary hemorrhage
- Auscultation: Crackles or reduced air entry may suggest pulmonary hemorrhage (rare) or infection
- Cough: Paroxysmal cough may explain mechanical petechiae
Cardiovascular Examination
- Perfusion: Capillary refill time (normal <2-3 seconds); mottling; temperature of extremities
- Heart sounds: Murmur may suggest endocarditis with embolic phenomena (rare in children)
- Pulse quality: Weak, thready pulses indicate poor cardiac output
- Blood pressure: Hypotension is a late sign of shock in children
Abdominal Examination
| Finding | Clinical Significance |
|---|---|
| Hepatomegaly | Leukemia, lymphoma, infectious mononucleosis, congenital infection |
| Splenomegaly | Leukemia, lymphoma, infectious mononucleosis, portal hypertension with sequestration |
| Hepatosplenomegaly | Highly concerning for hematological malignancy; also seen in storage disorders, infection |
| Abdominal tenderness | Henoch-Schönlein purpura may cause colicky abdominal pain; consider intussusception |
| Mass | Neuroblastoma (can present with “blueberry muffin” rash in neonates); Wilms tumor |
Musculoskeletal Examination
- Joint swelling or tenderness: Henoch-Schönlein purpura commonly affects ankles and knees; leukemia may cause bone pain
- Hemarthrosis: Suggests severe coagulation factor deficiency (hemophilia) rather than platelet disorder
- Limb deformity: Absent radius (thrombocytopenia-absent radius syndrome)
- Bone tenderness: May indicate marrow infiltration (leukemia) or bone infarction
Genitourinary Examination
- Scrotal swelling or purpura: Henoch-Schönlein purpura can cause scrotal involvement; must be differentiated from testicular torsion
- Signs of urethral bleeding: May indicate severe thrombocytopenia
Neurological Examination
- Level of consciousness: Reduced consciousness may indicate intracranial hemorrhage, meningitis, or severe sepsis
- Fontanelle (in infants): Bulging fontanelle suggests raised intracranial pressure
- Focal neurological signs: May indicate intracranial hemorrhage
- Signs of meningeal irritation: Neck stiffness, photophobia, positive Kernig/Brudzinski signs
Growth Parameters
- Plot weight, height, and head circumference: Failure to thrive may suggest chronic illness, malignancy, or syndromic condition
- Microcephaly: May indicate congenital infection associated with thrombocytopenia
Expected Findings by Etiology
| Condition | General Appearance | Skin Findings | Other Key Findings |
|---|---|---|---|
| Mechanical Petechiae | Well, afebrile, active | Petechiae localized to face, neck, upper chest; no mucosal involvement | Normal examination otherwise; history of coughing, vomiting, or crying |
| Immune Thrombocytopenic Purpura | Well, active, often post-viral illness | Generalized petechiae and bruising; may have mucosal petechiae if severe | No hepatosplenomegaly or lymphadenopathy; otherwise normal examination |
| Henoch-Schönlein Purpura | May have low-grade fever; ambulatory | Palpable purpura on lower extremities and buttocks; may have urticarial lesions initially | Joint swelling (ankles, knees); abdominal tenderness; scrotal swelling in boys; hypertension if nephritis |
| Meningococcemia | Ill-appearing, febrile, may be in shock | Rapidly evolving petechiae/purpura; may see necrotic lesions with gray centers | Poor perfusion; tachycardia; hypotension (late); meningism; altered mental status |
| Leukemia | Pale, fatigued, may have fever | Generalized petechiae and bruising; pallor | Hepatosplenomegaly; lymphadenopathy; bone tenderness; gum hypertrophy (AML) |
| Non-Accidental Injury | May appear well; inconsistent caregiver interaction | Patterned bruising; bruises of different ages; unusual locations (ears, neck, trunk) | May have other injuries; developmental concerns; safeguarding concerns |
Important Teaching Point
A well-appearing child with localized petechiae may have benign mechanical cause, but serious conditions must still be excluded. The key differentiating factors are:
- Is the child febrile? (If yes, treat as potential sepsis)
- Is the child truly well-appearing? (Serial observations may be needed)
- Are petechiae localized above the nipple line with a clear precipitant? (Suggests mechanical cause)
- Is there mucosal involvement? (Indicates more severe bleeding tendency)
- Are there any other concerning features on history or examination?
When in doubt, obtain a complete blood count to check platelet count and blood film.
5. Differential Diagnosis
Systematic approach organized by probability, clinical features, and age
Step-by-Step Approach to Petechiae and Purpura:
- Step 1: Assess clinical status — Is the child well or unwell? Febrile or afebrile?
- Step 2: Characterize the rash — Distribution, palpability, size, progression
- Step 3: Consider the “Big Four” — Mechanical causes, immune thrombocytopenic purpura, Henoch-Schönlein purpura, and serious infection
- Step 4: Look for red flags suggesting malignancy or bone marrow failure
- Step 5: Consider age-specific causes and non-accidental injury when appropriate
Febrile Child with Petechiae or Purpura
Critical Point
A febrile child with petechiae or purpura must be treated as having meningococcemia or sepsis until proven otherwise. While most febrile children with petechiae have viral infections, approximately 2-3% have serious bacterial infection, and 7-10% in endemic areas have meningococcal disease. Early antibiotics save lives.
| Probability | Condition | Key Features | Red Flags |
|---|---|---|---|
| COMMON (approximately 85-90%) | Viral infection with petechiae | Well-appearing; petechiae often localized (face/chest from coughing); may have viral symptoms | Becoming more unwell; spreading rash; poor perfusion |
| COMMON | Viral infection with thrombocytopenia | Generalized petechiae; may follow or accompany viral illness; child often relatively well | Mucosal bleeding; severely low platelet count |
| LESS COMMON (approximately 7-10%) | Meningococcemia | Ill-appearing; rapidly progressive; petechiae evolve to purpura; may have meningism | All features are red flags — treat immediately |
| LESS COMMON | Other bacterial sepsis | Ill-appearing; may have focus of infection; petechiae with disseminated intravascular coagulation | Shock; coagulopathy; multi-organ dysfunction |
| LESS COMMON | Henoch-Schönlein purpura with fever | Palpable purpura on lower limbs/buttocks; low-grade fever; joint pain; abdominal pain | Severe abdominal pain (intussusception); gross hematuria; hypertension |
| UNCOMMON BUT SERIOUS (approximately 2-3%) | Leukemia presenting with fever | Pallor; fatigue; hepatosplenomegaly; lymphadenopathy; bone pain | All features warrant urgent investigation |
| UNCOMMON | Rickettsial infection | Travel or tick exposure; fever; headache; rash spreads centripetally (starts on extremities) | Altered mental status; multi-organ involvement |
| UNCOMMON | Dengue fever | Travel to endemic area; fever; severe headache; retro-orbital pain; thrombocytopenia | Dengue hemorrhagic fever; shock syndrome |
Afebrile, Well Child with Petechiae or Purpura
| Probability | Condition | Key Features | Differentiating Factors |
|---|---|---|---|
| COMMON (approximately 50-60%) | Mechanical petechiae | Localized to face, neck, upper chest (superior vena cava distribution); history of coughing, vomiting, crying, straining | No mucosal involvement; no lesions below nipple line; child completely well; resolves in days |
| COMMON (approximately 20-30%) | Immune thrombocytopenic purpura | Sudden onset of generalized petechiae and bruising; often 1-4 weeks post-viral illness; otherwise well child | No hepatosplenomegaly; no lymphadenopathy; isolated thrombocytopenia on blood count |
| COMMON | Henoch-Schönlein purpura | Palpable purpura on lower extremities and buttocks; may have joint pain, abdominal pain | Normal platelet count; often follows upper respiratory tract infection; peak age 3-10 years |
| LESS COMMON (approximately 5-10%) | Accidental trauma | Bruising on shins, knees, forehead; mobile child; history consistent with location | Normal developmental stage; bruising in expected locations for activity level |
| LESS COMMON | von Willebrand disease | Easy bruising; epistaxis; menorrhagia in adolescent females; family history | Normal platelet count; prolonged bleeding time or PFA-100; may have low factor VIII |
| UNCOMMON BUT SERIOUS | Leukemia (early presentation) | Fatigue; pallor; bone pain; may initially appear relatively well | Abnormalities on complete blood count; hepatosplenomegaly; lymphadenopathy |
| UNCOMMON | Non-accidental injury | Bruising in unusual locations; patterned injuries; inconsistent history | Non-mobile infant with bruising; TEN-4 locations; safeguarding concerns |
| UNCOMMON | Inherited platelet disorders | Lifelong history of easy bruising; may have associated features (deafness, nephritis, skeletal abnormalities) | Family history; specific platelet abnormalities on blood film; specialized testing required |
Differential Diagnosis by Age
| Age Group | Common Causes | Less Common but Important | Key Considerations |
|---|---|---|---|
| Neonate (0-28 days) | Neonatal alloimmune thrombocytopenia; sepsis; birth trauma; congenital infection (TORCH) | Neonatal autoimmune thrombocytopenia (maternal immune thrombocytopenic purpura); inherited thrombocytopenias; vitamin K deficiency bleeding; neuroblastoma | Always check if vitamin K was given; consider maternal platelet history; “blueberry muffin” rash suggests extramedullary hematopoiesis |
| Infant (1-12 months) | Viral infections; sepsis; mechanical (from crying) | Non-accidental injury; Wiskott-Aldrich syndrome; Kasabach-Merritt phenomenon | High index of suspicion for non-accidental injury — “those who don’t cruise rarely bruise” |
| Toddler (1-3 years) | Immune thrombocytopenic purpura; Henoch-Schönlein purpura; viral infections; mechanical; accidental trauma | Leukemia; hemolytic uremic syndrome; meningococcemia | Peak age for immune thrombocytopenic purpura; bruising on shins common from normal toddler falls |
| School age (4-12 years) | Henoch-Schönlein purpura; immune thrombocytopenic purpura; mechanical; accidental trauma | Leukemia; aplastic anemia; von Willebrand disease | Peak age for Henoch-Schönlein purpura (3-10 years); consider inherited bleeding disorders if recurrent |
| Adolescent (13-18 years) | Immune thrombocytopenic purpura (may become chronic); mechanical; accidental trauma | Systemic lupus erythematosus; drug-induced thrombocytopenia; infectious mononucleosis; von Willebrand disease | Consider autoimmune conditions (especially systemic lupus erythematosus in females); ask about menorrhagia; drug and medication history important |
Mechanistic Approach: Causes by Pathophysiology
Decreased Platelet Production
Bone marrow failure:
• Leukemia, lymphoma
• Aplastic anemia
• Myelodysplastic syndrome
• Bone marrow infiltration (neuroblastoma)
Marrow suppression:
• Viral infections (parvovirus B19, EBV, CMV)
• Medications, chemotherapy
• Radiation
Inherited:
• Fanconi anemia
• Congenital amegakaryocytic thrombocytopenia
• Thrombocytopenia-absent radius syndrome
Increased Platelet Destruction
Immune-mediated:
• Immune thrombocytopenic purpura
• Neonatal alloimmune thrombocytopenia
• Drug-induced immune thrombocytopenia
• Systemic lupus erythematosus
• Evans syndrome
Non-immune consumption:
• Disseminated intravascular coagulation
• Hemolytic uremic syndrome
• Thrombotic thrombocytopenic purpura
• Kasabach-Merritt phenomenon
• Sepsis
Vascular Causes (Vasculitis/Damage)
Small vessel vasculitis:
• Henoch-Schönlein purpura (IgA vasculitis)
• Hypersensitivity vasculitis
• Drug-induced vasculitis
Infectious:
• Meningococcemia
• Rocky Mountain spotted fever
• Infective endocarditis
Mechanical:
• Increased venous pressure (coughing, vomiting)
• Tourniquet effect
Connective tissue disorders:
• Ehlers-Danlos syndrome
• Scurvy (vitamin C deficiency)
Platelet Dysfunction / Coagulation Disorders
Inherited platelet dysfunction:
• Glanzmann thrombasthenia
• Bernard-Soulier syndrome
• Storage pool disorders
von Willebrand disease
Acquired platelet dysfunction:
• Uremia
• Medications (aspirin, NSAIDs)
Coagulation factor deficiencies:
• Hemophilia A and B (usually deep bleeding, not petechiae)
• Vitamin K deficiency
• Liver disease
Drug-Induced Causes of Petechiae and Purpura
| Drug or Drug Class | Mechanism | Characteristics | Time to Onset / Resolution |
|---|---|---|---|
| Valproic acid | Dose-dependent bone marrow suppression; may also cause platelet dysfunction | Thrombocytopenia usually mild to moderate; reversible | Onset: weeks to months; Resolution: days to weeks after dose reduction or cessation |
| Trimethoprim-sulfamethoxazole | Immune-mediated platelet destruction; also folate antagonism | Can cause severe thrombocytopenia; may be rapid onset | Onset: days to weeks; Resolution: usually within 1-2 weeks of stopping |
| Penicillins and cephalosporins | Immune-mediated (drug-dependent antibodies) | Rare; can be severe | Onset: 7-14 days after starting; Resolution: days after stopping |
| Carbamazepine | Bone marrow suppression; rarely immune-mediated | Usually mild; rare aplastic anemia | Onset: weeks to months; Regular monitoring recommended |
| Heparin | Heparin-induced thrombocytopenia (immune-mediated) | Rare in children; paradoxical thrombosis risk | Onset: 5-10 days (or sooner with prior exposure); Resolution: days after stopping |
| Chemotherapy agents | Bone marrow suppression (myelosuppression) | Expected effect; dose-limiting toxicity for many agents | Onset: days to weeks (nadir typically 7-14 days); Recovery: 2-4 weeks |
| Aspirin and NSAIDs | Platelet dysfunction (cyclooxygenase inhibition); not thrombocytopenia | Increased bruising and bleeding with normal platelet count | Aspirin: irreversible (7-10 days); NSAIDs: reversible (24-48 hours) |
| MMR vaccine | Immune-mediated (post-vaccination immune thrombocytopenic purpura) | Transient thrombocytopenia; usually self-limited | Onset: 1-6 weeks post-vaccination; Resolution: usually within weeks |
Inherited Thrombocytopenias and Platelet Disorders
| Condition | Inheritance | Key Features | Diagnostic Clues |
|---|---|---|---|
| Wiskott-Aldrich syndrome | X-linked recessive | Triad: thrombocytopenia with small platelets, eczema, immunodeficiency; recurrent infections | Low mean platelet volume; affected males; eczema in infancy |
| Thrombocytopenia-absent radius syndrome | Autosomal recessive | Bilateral absent radii with thumbs present; thrombocytopenia worst in infancy, improves with age | Skeletal abnormalities apparent at birth; platelet count often improves after first year |
| Bernard-Soulier syndrome | Autosomal recessive | Giant platelets; moderate thrombocytopenia; mucocutaneous bleeding | Very large platelets on blood film; absent platelet aggregation to ristocetin |
| MYH9-related disorders | Autosomal dominant | Giant platelets; variable features including nephritis, deafness, cataracts | Döhle-like bodies in neutrophils; family history; variable severity |
| Glanzmann thrombasthenia | Autosomal recessive | Normal platelet count but severe bleeding; mucocutaneous hemorrhage | Normal count; absent aggregation to all agonists except ristocetin |
| Fanconi anemia | Autosomal recessive | Pancytopenia (develops over time); short stature; skeletal anomalies; café-au-lait spots | Chromosome breakage studies; physical anomalies present in 75% |
| Congenital amegakaryocytic thrombocytopenia | Autosomal recessive | Severe thrombocytopenia from birth; progresses to aplastic anemia | Absent or severely reduced megakaryocytes on marrow; MPL gene mutations |
Quick Reference: “If You See This, Think This”
| Clinical Clue | Think This First | Next Step |
|---|---|---|
| Febrile, ill child with rapidly spreading petechiae/purpura | Meningococcemia | Immediate IV antibiotics (ceftriaxone); resuscitation; do not delay for investigations |
| Well child, petechiae only above nipple line, history of coughing/vomiting | Mechanical petechiae | Consider checking complete blood count to confirm normal platelets; reassurance if well |
| Well child, generalized petechiae, recent viral illness | Immune thrombocytopenic purpura | Complete blood count; blood film; refer to pediatric hematology |
| Palpable purpura on buttocks and lower extremities | Henoch-Schönlein purpura (IgA vasculitis) | Urinalysis; blood pressure; assess for abdominal and joint involvement |
| Pallor, fatigue, hepatosplenomegaly, lymphadenopathy | Leukemia | Urgent complete blood count with differential and blood film; immediate referral |
| Purpura with bloody diarrhea following gastroenteritis | Hemolytic uremic syndrome | Complete blood count; blood film for schistocytes; renal function; urgent nephrology referral |
| Non-mobile infant with bruising | Non-accidental injury (until proven otherwise) | Skeletal survey; ophthalmology exam; coagulation studies; safeguarding referral |
| Neonate with petechiae, maternal history of immune thrombocytopenic purpura | Neonatal autoimmune thrombocytopenia | Neonatal platelet count; monitor for bleeding; usually self-resolves |
| Thrombocytopenia with eczema in male infant | Wiskott-Aldrich syndrome | Check mean platelet volume (small platelets); genetic testing; immunology referral |
| Adolescent female with easy bruising and heavy periods | von Willebrand disease | von Willebrand factor antigen and activity; factor VIII level; platelet function testing |
6. Diagnostic Investigations
A stepwise, clinically guided approach to investigation
Critical Point: When NOT to Delay for Investigations
In a febrile, ill-appearing child with petechiae or purpura, do not delay antibiotics to obtain investigations. Give intravenous ceftriaxone immediately after obtaining blood cultures if possible, but do not wait for blood culture results or other tests before treating suspected meningococcemia.
First-Line Investigations: All Children with Unexplained Petechiae or Purpura
| Investigation | Purpose | What to Look For | Practical Points |
|---|---|---|---|
| Complete blood count with differential | Assess platelet count; detect anemia, leukocytosis, or pancytopenia | Platelet count (normal 150-400 × 10⁹/L); hemoglobin; white cell count and differential | Essential first test; if platelets normal, consider vascular or coagulation cause |
| Blood film (peripheral smear) | Assess platelet morphology; detect blasts, schistocytes, abnormal cells | Platelet size (large in immune thrombocytopenic purpura, small in Wiskott-Aldrich); blasts (leukemia); schistocytes (microangiopathic hemolytic anemia) | Should be reviewed by hematologist; critical for excluding leukemia |
| Coagulation studies (PT, aPTT) | Assess coagulation cascade integrity | Prothrombin time (PT); activated partial thromboplastin time (aPTT); usually normal in platelet disorders | Prolonged in disseminated intravascular coagulation, liver disease, factor deficiencies, vitamin K deficiency |
| Blood group and antibody screen | Prepare for potential transfusion | ABO and Rh type; presence of antibodies | Essential if severe thrombocytopenia or active bleeding; anticipate transfusion need |
Second-Line Investigations: Based on Clinical Suspicion
If Suspecting Immune Thrombocytopenic Purpura
Usually Sufficient
- Complete blood count and film: Isolated thrombocytopenia; large platelets; no blasts; normal hemoglobin and white cells
- Reticulocyte count: Normal (helps exclude hemolysis or marrow failure)
Immune thrombocytopenic purpura is a clinical diagnosis — bone marrow examination is NOT routinely required in typical presentations.
Consider If Atypical Features
- Bone marrow aspirate: Only if atypical features (abnormal white cells, anemia, hepatosplenomegaly, or treatment failure)
- Direct antiglobulin test (Coombs): If hemolysis suspected (Evans syndrome = autoimmune hemolytic anemia plus immune thrombocytopenic purpura)
- Immunoglobulin levels: If recurrent infections (exclude common variable immunodeficiency)
- Antinuclear antibody, anti-dsDNA: If adolescent female or features of systemic lupus erythematosus
If Suspecting Henoch-Schönlein Purpura (IgA Vasculitis)
First-Line Tests
- Urinalysis: Check for hematuria and proteinuria (nephritis occurs in up to 50%)
- Blood pressure: Hypertension suggests nephritis
- Urea and creatinine: Assess renal function
- Complete blood count: Platelet count should be normal or elevated (not low)
If Renal Involvement Suspected
- Urine protein:creatinine ratio: Quantify proteinuria
- Serum albumin: If significant proteinuria
- Complement levels (C3, C4): Usually normal in Henoch-Schönlein purpura (helps differentiate from post-infectious glomerulonephritis)
- Renal biopsy: If severe or progressive nephritis; shows IgA deposits
If Suspecting Sepsis or Meningococcemia
| Investigation | Purpose | Key Findings |
|---|---|---|
| Blood cultures | Identify causative organism | Obtain before antibiotics if possible, but do not delay treatment |
| Lumbar puncture | Diagnose meningitis; obtain cerebrospinal fluid culture | Only if safe (no signs of raised intracranial pressure, not coagulopathic); may defer if unstable |
| Meningococcal PCR (blood and cerebrospinal fluid) | Rapid diagnosis; positive even after antibiotics started | Highly sensitive and specific; useful when cultures negative |
| Coagulation studies (PT, aPTT, fibrinogen, D-dimer) | Detect disseminated intravascular coagulation | Prolonged PT/aPTT; low fibrinogen; elevated D-dimer; falling platelets |
| Lactate | Marker of tissue hypoperfusion | Elevated lactate indicates shock and poor prognosis |
| Blood gas | Assess acid-base status and oxygenation | Metabolic acidosis in septic shock |
| C-reactive protein and procalcitonin | Markers of bacterial infection | Elevated in bacterial sepsis; procalcitonin more specific for bacterial infection |
If Suspecting Leukemia or Bone Marrow Failure
Initial Workup
- Complete blood count with differential: May show pancytopenia, blasts, abnormal white cell count
- Blood film: Essential — look for blast cells
- Lactate dehydrogenase: Elevated in high cell turnover
- Uric acid: Elevated; risk of tumor lysis syndrome
- Renal and liver function: Baseline before treatment
Definitive Diagnosis
- Bone marrow aspirate and trephine biopsy: Essential for diagnosis, classification, and cytogenetics
- Flow cytometry: Immunophenotyping of blast cells
- Cytogenetics and molecular studies: Prognostic and therapeutic implications
- Chest X-ray: Mediastinal mass (T-cell acute lymphoblastic leukemia)
If Suspecting Inherited Bleeding Disorder
| Suspected Condition | First-Line Tests | Confirmatory Tests |
|---|---|---|
| von Willebrand disease | Complete blood count (usually normal); PT/aPTT (aPTT may be prolonged); PFA-100 or bleeding time (prolonged) | von Willebrand factor antigen; von Willebrand factor activity (ristocetin cofactor); factor VIII level; multimer analysis for typing |
| Platelet function disorders | Complete blood count (normal or low platelets); blood film (may show large platelets); PFA-100 (prolonged) | Platelet aggregation studies; platelet flow cytometry; electron microscopy; genetic testing |
| Inherited thrombocytopenia | Complete blood count; blood film (platelet size); mean platelet volume | Genetic testing; specific syndrome evaluation (immunology, audiology, ophthalmology as indicated) |
If Suspecting Non-Accidental Injury
Investigation of Suspected Non-Accidental Injury
- Complete blood count and coagulation studies: To exclude bleeding disorder (but remember bleeding disorders and abuse can coexist)
- Skeletal survey: Full radiographic skeletal survey for occult fractures
- Ophthalmology examination: Dilated fundoscopy for retinal hemorrhages
- CT or MRI head: If intracranial injury suspected
- Photography: Document injuries with measurements and color reference
- Safeguarding referral: Multi-disciplinary assessment essential
Important: A normal coagulation screen does not exclude non-accidental injury. A full hematological workup including von Willebrand studies and platelet function may be required.
Interpretation of Key Laboratory Findings
| Finding | Interpretation | Conditions to Consider |
|---|---|---|
| Isolated thrombocytopenia (normal hemoglobin and white cells) | Suggests immune thrombocytopenic purpura or isolated platelet problem | Immune thrombocytopenic purpura; drug-induced; neonatal alloimmune; inherited thrombocytopenia |
| Pancytopenia (low platelets, hemoglobin, and white cells) | Suggests bone marrow problem | Leukemia; aplastic anemia; marrow infiltration; severe infection; myelodysplasia |
| Thrombocytopenia with schistocytes (fragmented red cells) | Microangiopathic hemolytic anemia | Hemolytic uremic syndrome; thrombotic thrombocytopenic purpura; disseminated intravascular coagulation |
| Thrombocytopenia with blast cells on film | Leukemia until proven otherwise | Acute lymphoblastic leukemia; acute myeloid leukemia — urgent referral |
| Normal platelet count with palpable purpura | Vasculitis | Henoch-Schönlein purpura; other small vessel vasculitis; septic emboli |
| Normal platelet count with petechiae/bruising | Platelet dysfunction or coagulation problem | von Willebrand disease; platelet function disorder; coagulation factor deficiency |
| Prolonged PT and aPTT with low fibrinogen | Disseminated intravascular coagulation | Sepsis; severe infection; malignancy (especially acute promyelocytic leukemia) |
| Very small platelets with low platelet count | Suggests Wiskott-Aldrich syndrome | X-linked; associated with eczema and immunodeficiency |
| Very large platelets | May indicate inherited macrothrombocytopenia or immune thrombocytopenic purpura | Bernard-Soulier syndrome; MYH9-related disorders; immune thrombocytopenic purpura (young platelets) |
Pediatric Reference Ranges
| Parameter | Neonate | Infant (1-12 months) | Child (1-12 years) | Adolescent |
|---|---|---|---|---|
| Platelet count (× 10⁹/L) | 150-400 | 150-400 | 150-400 | 150-400 |
| Mean platelet volume (fL) | 7.0-10.5 | 7.0-10.5 | 7.5-11.0 | 7.5-11.5 |
| PT (seconds) | 10-16 | 10-14 | 11-14 | 11-14 |
| aPTT (seconds) | 25-60 | 25-40 | 25-35 | 25-35 |
| Fibrinogen (g/L) | 1.5-3.0 | 1.5-4.0 | 2.0-4.0 | 2.0-4.0 |
Practical Approach: Investigation Strategy by Clinical Scenario
| Clinical Scenario | Minimum Workup | Additional If Indicated |
|---|---|---|
| Well child, localized petechiae above nipple line, clear mechanical cause | Complete blood count to confirm normal platelets (can be deferred if very confident of diagnosis) | None if well and platelets normal |
| Well child, generalized petechiae, suspected immune thrombocytopenic purpura | Complete blood count; blood film; blood group | Reticulocyte count; Coombs test if anemia; bone marrow only if atypical |
| Palpable purpura, suspected Henoch-Schönlein purpura | Complete blood count; urinalysis; blood pressure; renal function | Urine protein:creatinine; renal biopsy if severe nephritis |
| Febrile child with petechiae — suspected sepsis | Blood cultures; complete blood count; coagulation studies; blood gas; lactate | Lumbar puncture if safe; meningococcal PCR; inflammatory markers |
| Suspected non-accidental injury | Complete blood count; PT; aPTT; skeletal survey; ophthalmology exam | von Willebrand studies; platelet function testing; CT/MRI head |
7. Clinical Decision-Making
Practical algorithms and decision pathways for petechiae and purpura in children
Step 1: Is This Urgent? — Triage Assessment
| Clinical Scenario | Urgency Level | Immediate Action |
|---|---|---|
| Febrile, ill-appearing child with petechiae/purpura | EMERGENT | IV access; blood cultures; immediate IV ceftriaxone; fluid resuscitation if shocked; do NOT delay antibiotics for any investigations |
| Rapidly spreading purpura (minutes to hours) | EMERGENT | Treat as meningococcemia; IV antibiotics immediately; prepare for intensive care admission; monitor for shock |
| Signs of shock (poor perfusion, tachycardia, altered mental status) | EMERGENT | Activate resuscitation team; IV fluid bolus 20 mL/kg; early inotropic support; intensive care admission |
| Active mucosal bleeding or signs of intracranial hemorrhage | EMERGENT | Urgent platelet transfusion if thrombocytopenic; CT head if neurological symptoms; hematology consultation; avoid lumbar puncture |
| Pallor with petechiae, suspected leukemia | URGENT | Urgent complete blood count and blood film; do not delay — contact pediatric hematology/oncology same day |
| Severe thrombocytopenia (platelets less than 20 × 10⁹/L) | URGENT | Admit for observation; hematology consultation; activity restriction; consider treatment if bleeding |
| Henoch-Schönlein purpura with severe abdominal pain | URGENT | Consider intussusception; abdominal ultrasound; surgical consultation if obstruction suspected; monitor hydration |
| Non-mobile infant with unexplained bruising | URGENT | Full evaluation for non-accidental injury AND bleeding disorder; safeguarding referral; skeletal survey; ophthalmology exam |
| Well child with generalized petechiae, no fever | URGENT | Same-day complete blood count and blood film; if isolated thrombocytopenia with well child, likely immune thrombocytopenic purpura — refer to hematology |
| Well child with localized petechiae above nipple line, clear mechanical cause | ROUTINE | Consider complete blood count to confirm normal platelets; reassurance if well with normal count; safety-net advice |
| Henoch-Schönlein purpura, mild symptoms, normal urinalysis | ROUTINE | Outpatient management; symptomatic treatment; weekly urinalysis for 4-6 weeks; blood pressure monitoring |
Step 2: Initial Clinical Assessment Algorithm
Key Decision Points:
- Is the child febrile?
- YES + ill-appearing → Treat as sepsis/meningococcemia immediately
- YES + well-appearing → Still concerning; obtain urgent investigations; observe closely
- NO → Proceed to step 2
- Is the child well or unwell?
- Unwell (pallor, fatigue, hepatosplenomegaly) → Urgent evaluation for leukemia/marrow failure
- Well → Proceed to step 3
- What is the distribution of the rash?
- Localized above nipple line with mechanical trigger → Likely benign; confirm with complete blood count
- Lower extremities/buttocks + palpable → Think Henoch-Schönlein purpura
- Generalized → Think thrombocytopenia; obtain urgent complete blood count
- What does the complete blood count show?
- Isolated thrombocytopenia → Likely immune thrombocytopenic purpura if otherwise well
- Pancytopenia or blasts → Urgent hematology referral for suspected leukemia
- Normal platelets → Consider vasculitis, coagulation disorder, or platelet dysfunction
Step 3: Management Pathways by Diagnosis
Pathway A: Suspected Meningococcemia or Sepsis
| Step | Action | Key Points |
|---|---|---|
| 1 | Recognize and escalate | Febrile + petechiae/purpura + ill = meningococcemia until proven otherwise; call for senior help immediately |
| 2 | IV/IO access and antibiotics | IV ceftriaxone 80-100 mg/kg (max 4g) IMMEDIATELY; do not wait for investigations; IM if IV access delayed |
| 3 | Fluid resuscitation | 20 mL/kg 0.9% saline bolus; repeat as needed; early inotropes if fluid-refractory shock |
| 4 | Obtain investigations | Blood cultures, complete blood count, coagulation, blood gas, lactate, glucose; meningococcal PCR; lumbar puncture only if safe |
| 5 | Intensive care admission | All suspected meningococcemia requires intensive care monitoring; anticipate multi-organ failure |
| 6 | Public health notification | Notify public health; arrange chemoprophylaxis for close contacts (ciprofloxacin or rifampicin) |
Pathway B: Immune Thrombocytopenic Purpura
| Platelet Count | Bleeding Status | Management Approach |
|---|---|---|
| Greater than 30 × 10⁹/L | No significant bleeding | Observation only (“watch and wait”); activity modification; avoid contact sports; avoid aspirin/NSAIDs; safety-net advice |
| 20-30 × 10⁹/L | Minor bleeding (petechiae, bruising) | Consider observation vs. treatment based on symptoms, family anxiety, practicality of follow-up; discuss with hematology |
| Less than 20 × 10⁹/L | Minor bleeding | Treatment often indicated; options include oral corticosteroids (prednisone 1-2 mg/kg/day) or IV immunoglobulin (0.8-1 g/kg) |
| Any count | Significant mucosal bleeding | Admit; IV immunoglobulin (rapid platelet rise); consider corticosteroids; tranexamic acid for mucosal bleeding |
| Any count | Life-threatening bleeding or suspected intracranial hemorrhage | Platelet transfusion; IV immunoglobulin; IV methylprednisolone; urgent CT head; intensive care admission; consider emergency splenectomy in refractory cases |
Key Points for Immune Thrombocytopenic Purpura Management
- Most children (80%) recover spontaneously within 6 months regardless of treatment
- Treatment raises platelet count faster but does not change long-term outcome
- Platelet transfusion is generally NOT indicated unless life-threatening bleeding (transfused platelets are rapidly destroyed)
- Bone marrow examination is NOT routinely required in typical presentations
- Avoid intramuscular injections and lumbar puncture until platelet count improves
Pathway C: Henoch-Schönlein Purpura (IgA Vasculitis)
| Presentation | Management | Monitoring |
|---|---|---|
| Rash only, no systemic symptoms | Supportive care; rest; adequate hydration; no specific treatment required | Weekly urinalysis and blood pressure for at least 4-6 weeks; some recommend up to 6 months |
| Arthritis/arthralgia | NSAIDs for pain (ibuprofen, naproxen); rest; elevation of affected joints | Joint symptoms usually resolve within days to weeks; no long-term sequelae |
| Mild abdominal pain | Supportive care; analgesia; ensure adequate hydration; soft diet if needed | Watch for signs of intussusception (severe colicky pain, vomiting, bloody stool) |
| Severe abdominal pain | Hospital admission; IV fluids; consider corticosteroids (prednisone 1-2 mg/kg/day); surgical consultation; abdominal ultrasound to exclude intussusception | Close monitoring; may need endoscopy if gastrointestinal bleeding significant |
| Renal involvement (hematuria and/or proteinuria) | Nephrology referral; ACE inhibitors if significant proteinuria; corticosteroids controversial; consider biopsy if severe | Long-term follow-up; blood pressure; urine protein:creatinine ratio; renal function |
| Scrotal involvement | Doppler ultrasound to exclude testicular torsion; supportive care with scrotal elevation; analgesia | Usually resolves spontaneously; surgical exploration only if torsion cannot be excluded |
“What Do I Do If…” — Common Clinical Scenarios
| Clinical Situation | Immediate Action | Next Steps |
|---|---|---|
| Well child with facial petechiae after vomiting episode | Examine for petechiae elsewhere; check for mucosal involvement; assess wellbeing | If isolated to face/upper chest, well child, and no mucosal bleeding → consider complete blood count to confirm; reassurance if normal |
| Parent notices new bruises daily despite treatment for immune thrombocytopenic purpura | Recheck platelet count; assess for new symptoms; review medication compliance | If platelets rising but still low, new bruises expected; if count not responding after 1-2 weeks, reconsider diagnosis |
| Child with immune thrombocytopenic purpura develops fever | Full sepsis evaluation; blood cultures; complete blood count | If on corticosteroids, increased infection risk; treat any infection aggressively; reassess immune thrombocytopenic purpura management |
| Henoch-Schönlein purpura patient develops colicky abdominal pain with vomiting | Suspect intussusception; urgent abdominal ultrasound; surgical consultation | If intussusception confirmed, air or contrast enema reduction; surgery if unsuccessful or perforation suspected |
| Previously well child with immune thrombocytopenic purpura now has severe headache | Suspect intracranial hemorrhage; immediate CT head (without lumbar puncture) | If hemorrhage present: platelet transfusion, IV immunoglobulin, high-dose steroids, neurosurgical consultation |
| Neonate with thrombocytopenia — mother has immune thrombocytopenic purpura | Check neonatal platelet count; cranial ultrasound to exclude intracranial hemorrhage | Usually self-resolves as maternal antibodies clear; IV immunoglobulin if significant bleeding or very low count |
| Child with petechiae but normal platelet count | Consider vasculitis, platelet function disorder, or coagulation problem | Check coagulation studies; if palpable purpura, think vasculitis; consider von Willebrand and platelet function testing |
| Family refuses hospital admission for severe thrombocytopenia | Explain risks clearly (intracranial hemorrhage); document discussion thoroughly | If child at significant risk and family refuses, consider safeguarding referral; involve senior staff; provide clear written safety-net advice |
When to Involve Specialists
Pediatric Hematology
- All confirmed immune thrombocytopenic purpura cases
- Suspected leukemia or bone marrow failure
- Thrombocytopenia not responding to treatment
- Suspected inherited bleeding or platelet disorder
- Chronic immune thrombocytopenic purpura (lasting more than 12 months)
- Need for bone marrow examination
Pediatric Nephrology
- Henoch-Schönlein purpura with significant renal involvement
- Hemolytic uremic syndrome
- Persistent proteinuria or hematuria
- Hypertension
- Declining renal function
Pediatric Rheumatology
- Suspected systemic lupus erythematosus
- Atypical vasculitis
- Recurrent Henoch-Schönlein purpura
- Multi-system autoimmune disease
Pediatric Surgery
- Suspected intussusception
- Acute abdomen in Henoch-Schönlein purpura
- Suspected testicular torsion
- Emergency splenectomy consideration
Safety-Netting and Discharge Advice
Advice for Parents: When to Return Immediately
- Fever develops — especially if child becomes unwell
- Rash is spreading quickly — new spots appearing over minutes to hours
- Child becomes more unwell — less active, not feeding, difficult to rouse
- Bleeding that won’t stop — nosebleed lasting more than 15-20 minutes despite pressure
- Blood in vomit, urine, or stool
- Severe headache — especially with vomiting or visual changes
- Severe tummy pain — especially with vomiting (for Henoch-Schönlein purpura patients)
- Swollen or painful testicle — for boys with Henoch-Schönlein purpura
Activity advice for thrombocytopenia: Avoid contact sports, rough play, and activities with high risk of head injury until platelet count has recovered.
8. Clinical Pearls and Pitfalls
Practical wisdom — learn from experience and avoid common mistakes
Must-Know Clinical Pearls
The glass test is your friend: Teach parents to press a clear glass against the rash. Petechiae and purpura do not blanch — if the spots disappear under pressure, it’s not petechiae.
Distribution is diagnostic: Petechiae above the nipple line (face, neck, upper chest) with a clear mechanical trigger in a well child is usually benign. Petechiae below the nipple line or generalized warrants investigation.
Palpable purpura means vasculitis: If you can feel the lesions (raised, palpable), think Henoch-Schönlein purpura or other vasculitis — the platelet count should be normal.
Immune thrombocytopenic purpura is a diagnosis of exclusion: The classic triad is isolated thrombocytopenia, well child, and absence of other causes. Always review the blood film to exclude leukemia.
Most children with immune thrombocytopenic purpura recover without treatment: Approximately 80% of children have spontaneous resolution within 6 months. Treatment speeds platelet recovery but does not change the natural history.
Bone marrow is NOT routine for typical immune thrombocytopenic purpura: If the child is otherwise well with isolated thrombocytopenia and a normal blood film (no blasts), bone marrow examination is not required before starting treatment.
Henoch-Schönlein purpura nephritis can occur weeks after the rash: Continue monitoring urinalysis weekly for at least 4-6 weeks, and some recommend up to 6 months. Most renal involvement occurs within the first 4-6 weeks.
“Those who don’t cruise rarely bruise”: Bruising in a non-mobile infant (under 6 months or not yet cruising) is highly suspicious for non-accidental injury or a significant bleeding disorder — investigate both.
Fever plus petechiae equals antibiotics first, questions later: In a febrile child with petechiae, give IV ceftriaxone immediately if there is any concern for sepsis. The risk of delaying antibiotics for meningococcemia far outweighs the risk of treating a viral illness.
Check vitamin K status in bleeding neonates: Always confirm that vitamin K was given at birth. Vitamin K deficiency bleeding can present in the first days to weeks of life and is preventable.
Critical Pitfalls to Avoid
Delaying antibiotics in febrile petechiae: Do not wait for investigation results, senior review, or lumbar puncture before giving antibiotics to an ill child with fever and petechiae. Minutes matter in meningococcemia.
Assuming all petechiae above the nipple line are benign: While mechanical petechiae are common, you must confirm the child is truly well and check a complete blood count if there is any doubt. A well-appearing child can still have serious underlying disease.
Missing leukemia by not reviewing the blood film: A normal complete blood count does not exclude leukemia — always ensure the blood film is reviewed by a hematologist. Blast cells may be present even with relatively normal counts.
Treating thrombocytopenia with platelets routinely: Platelet transfusion is NOT indicated for immune thrombocytopenic purpura unless there is life-threatening bleeding. Transfused platelets are rapidly destroyed and may worsen the immune response.
Forgetting to monitor urine in Henoch-Schönlein purpura: Renal involvement can develop weeks after the rash appears. Failing to monitor urinalysis can miss nephritis that may progress to chronic kidney disease.
Diagnosing immune thrombocytopenic purpura without excluding other causes: Check for hepatosplenomegaly, lymphadenopathy, and review the blood film before labeling isolated thrombocytopenia as immune thrombocytopenic purpura. These findings suggest leukemia or other serious conditions.
Assuming bruising in a mobile toddler is always innocent: While shin bruises are normal in toddlers, bruising in unusual locations (ears, neck, trunk, buttocks) should raise concern for non-accidental injury regardless of the child’s mobility.
Excluding abuse because a bleeding disorder is found: Bleeding disorders and non-accidental injury can coexist. Finding a coagulation abnormality does not exclude the possibility of abuse — complete the safeguarding evaluation.
Performing lumbar puncture in severe thrombocytopenia: Lumbar puncture is contraindicated when platelets are very low (generally less than 50 × 10⁹/L) due to risk of spinal hematoma. If meningitis is suspected and platelet count is low, treat empirically and defer lumbar puncture.
Forgetting intussusception in Henoch-Schönlein purpura with abdominal pain: Severe abdominal pain in Henoch-Schönlein purpura may indicate intussusception (ileo-ileal, unlike the typical ileo-colic in young children). Always consider this diagnosis and obtain imaging.
Key Takeaways
- First question: Is the child well or unwell? A febrile, ill child with petechiae is a medical emergency — give antibiotics immediately for suspected meningococcemia.
- Distribution matters: Petechiae localized above the nipple line with a mechanical trigger in a well child is usually benign; generalized or dependent distribution requires investigation.
- Palpability is key: Palpable purpura indicates vasculitis (normal platelet count expected); non-palpable petechiae suggest platelet or coagulation problem.
- The complete blood count and blood film are essential: These simple tests guide diagnosis — isolated thrombocytopenia suggests immune thrombocytopenic purpura, pancytopenia or blasts suggest leukemia.
- Immune thrombocytopenic purpura has an excellent prognosis: Most children recover spontaneously; treatment accelerates recovery but does not change outcomes; bone marrow is not routinely needed.
- Henoch-Schönlein purpura requires monitoring: Renal involvement can occur weeks after the rash; monitor urinalysis and blood pressure for at least 4-6 weeks.
- Non-mobile infants with bruising need full evaluation: Consider both non-accidental injury and bleeding disorders; a normal coagulation screen does not exclude abuse.
- Age-specific causes differ: Consider neonatal alloimmune thrombocytopenia in neonates, Wiskott-Aldrich syndrome in boys with small platelets and eczema, and systemic lupus erythematosus in adolescent females.
- Drug-induced causes are common: Always review medications, including over-the-counter drugs and recent vaccines (especially MMR).
- Safety-netting is critical: Ensure parents know when to return — fever, rapidly spreading rash, bleeding that won’t stop, severe headache, or child becoming more unwell.
Quick Reference Algorithm
Systematic Approach to Petechiae and Purpura in Children:
- Assess clinical status: Is the child febrile? Well or unwell? If febrile and ill → treat as sepsis/meningococcemia immediately with IV antibiotics.
- Characterize the rash: Location (above or below nipple line), palpability (flat or raised), distribution (localized or generalized), and progression (stable or spreading).
- Obtain basic investigations: Complete blood count with blood film is essential for all unexplained petechiae; add coagulation studies if bleeding or ill child.
- Interpret findings:
- Isolated thrombocytopenia + well child → likely immune thrombocytopenic purpura
- Pancytopenia or blasts → urgent hematology referral (suspect leukemia)
- Normal platelets + palpable purpura → vasculitis (Henoch-Schönlein purpura)
- Normal platelets + non-palpable petechiae → consider platelet dysfunction or coagulation disorder
- Manage according to diagnosis: Most immune thrombocytopenic purpura is managed expectantly; Henoch-Schönlein purpura requires renal monitoring; suspected sepsis requires immediate treatment and intensive care.
- Provide clear safety-net advice: Ensure parents know warning signs requiring immediate return — fever, spreading rash, bleeding, severe headache, abdominal pain, or child becoming unwell.
- Arrange appropriate follow-up: Hematology for immune thrombocytopenic purpura; weekly urinalysis for Henoch-Schönlein purpura; pediatric subspecialty as indicated.